Boston Scientific Exercises Option to Acquire Farapulse, Inc. prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
FARAPULSE Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation
News provided by
Share this article
- FARAPULSE becomes first company in the world to commercialize a cardiac PFA system -
MENLO PARK, Calif., Jan. 29, 2021 /PRNewswire/ - FARAPULSE Inc. ( FARAPULSE or the Company ) today announced that it has received the Conformité Européene (CE) Mark for its FARAPULSE Pulsed Field Ablation (PFA) system for the treatment of Paroxysmal Atrial Fibrillation (AF). The approval makes FARAPULSE the first company in the world to commercialize a cardiac PFA system and permits marketing of the system across the European Union and other CE Mark geographies. AF affects one in four adults during their lifetime and is a leading cause of stroke.